US Stock MarketDetailed Quotes

Entera Bio (ENTX)

Watchlist
  • 1.240
  • -0.080-6.06%
Trading May 15 11:53 ET
61.04MMarket Cap-4.77P/E (TTM)

Entera Bio (ENTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-120.09%-3.09M
-8.10%-7.37M
-24.95%-1.83M
-16.16%-2.5M
-22.17%-1.63M
24.60%-1.4M
6.73%-6.82M
43.94%-1.47M
-41.25%-2.15M
14.37%-1.34M
Net income from continuing operations
-36.54%-3.51M
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
Depreciation and amortization
-12.50%7K
-34.78%30K
-36.36%7K
-27.27%8K
-36.36%7K
-38.46%8K
-17.86%46K
-15.38%11K
-21.43%11K
-26.67%11K
Deferred tax
----
----
----
----
----
----
-51.72%14K
--14K
----
----
Other non cash items
250.00%6K
740.00%32K
700.00%40K
-750.00%-26K
540.00%22K
55.56%-4K
---5K
--5K
128.57%4K
-66.67%-5K
Change In working capital
-148.65%-270K
1,022.32%1.26M
44.41%426K
-177.63%-211K
136.41%487K
277.32%555K
157.44%112K
130.32%295K
-117.19%-76K
-26.95%206K
-Change in receivables
----
200.00%126K
510.71%345K
-2,400.00%-345K
----
----
-151.22%-126K
---84K
-48.28%15K
---57K
-Change in payables and accrued expense
-119.82%-176K
439.68%1.36M
67.69%436K
-28.42%-244K
63.74%280K
7,972.73%888K
150.70%252K
122.75%260K
-211.11%-190K
-38.71%171K
-Change in other current assets
71.77%-94K
-1,535.71%-229K
-398.32%-355K
281.82%378K
-11.96%81K
-2.78%-333K
-125.00%-14K
-30.00%119K
-59.09%99K
2,966.67%92K
Cash from discontinued investing activities
Operating cash flow
-120.09%-3.09M
-8.10%-7.37M
-24.95%-1.83M
-16.16%-2.5M
-22.17%-1.63M
24.60%-1.4M
6.73%-6.82M
43.94%-1.47M
-41.25%-2.15M
14.37%-1.34M
Investing cash flow
Cash flow from continuing investing activities
0
-3,466.67%-107K
-800.00%-27K
-43K
-29K
-8K
82.35%-3K
40.00%-3K
0
0
Net PPE purchase and sale
--0
-3,466.67%-107K
-800.00%-27K
---43K
---29K
---8K
82.35%-3K
40.00%-3K
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
-3,466.67%-107K
-800.00%-27K
---43K
---29K
---8K
82.35%-3K
40.00%-3K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-99.03%130K
206.30%13.71M
-94.59%174K
1,823.08%250K
-104.19%-51K
44,356.67%13.34M
-25.84%4.48M
-46.66%3.22M
13K
24,220.00%1.22M
Net common stock issuance
--0
239.49%13.44M
--0
--71K
--0
--13.37M
-40.15%3.96M
-49.48%3.34M
--0
--620K
Proceeds from stock option exercised by employees
-13.33%130K
-37.07%528K
-3.87%174K
1,284.62%180K
-96.10%24K
400.00%150K
--839K
--181K
--13K
--615K
Net other financing activities
----
18.89%-262K
--0
---1K
---75K
---186K
44.31%-323K
---304K
--0
----
Cash from discontinued financing activities
Financing cash flow
-99.03%130K
206.30%13.71M
-94.59%174K
1,823.08%250K
-104.19%-51K
44,356.67%13.34M
-25.84%4.48M
-46.66%3.22M
--13K
24,220.00%1.22M
Net cash flow
Beginning cash position
71.32%14.97M
-21.15%8.74M
138.64%16.69M
107.51%18.95M
123.33%20.67M
-21.15%8.74M
-10.43%11.09M
-8.90%6.99M
-0.73%9.13M
-13.97%9.25M
Current changes in cash
-124.82%-2.96M
367.33%6.27M
-194.45%-1.65M
-7.19%-2.3M
-1,337.82%-1.71M
750.93%11.93M
-81.64%-2.35M
-48.75%1.75M
-40.39%-2.14M
92.35%-119K
Effect of exchange rate changes
--4K
---36K
---65K
----
----
--0
--0
--0
----
----
End cash Position
-41.85%12.02M
71.32%14.97M
71.32%14.97M
138.64%16.69M
107.51%18.95M
123.33%20.67M
-21.15%8.74M
-21.15%8.74M
-8.90%6.99M
-0.73%9.13M
Free cash flow
-118.84%-3.09M
-9.62%-7.48M
-26.53%-1.86M
-18.15%-2.55M
-24.34%-1.66M
24.17%-1.41M
6.91%-6.82M
43.94%-1.47M
-41.25%-2.15M
14.42%-1.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -120.09%-3.09M-8.10%-7.37M-24.95%-1.83M-16.16%-2.5M-22.17%-1.63M24.60%-1.4M6.73%-6.82M43.94%-1.47M-41.25%-2.15M14.37%-1.34M
Net income from continuing operations -36.54%-3.51M-19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M
Depreciation and amortization -12.50%7K-34.78%30K-36.36%7K-27.27%8K-36.36%7K-38.46%8K-17.86%46K-15.38%11K-21.43%11K-26.67%11K
Deferred tax -------------------------51.72%14K--14K--------
Other non cash items 250.00%6K740.00%32K700.00%40K-750.00%-26K540.00%22K55.56%-4K---5K--5K128.57%4K-66.67%-5K
Change In working capital -148.65%-270K1,022.32%1.26M44.41%426K-177.63%-211K136.41%487K277.32%555K157.44%112K130.32%295K-117.19%-76K-26.95%206K
-Change in receivables ----200.00%126K510.71%345K-2,400.00%-345K---------151.22%-126K---84K-48.28%15K---57K
-Change in payables and accrued expense -119.82%-176K439.68%1.36M67.69%436K-28.42%-244K63.74%280K7,972.73%888K150.70%252K122.75%260K-211.11%-190K-38.71%171K
-Change in other current assets 71.77%-94K-1,535.71%-229K-398.32%-355K281.82%378K-11.96%81K-2.78%-333K-125.00%-14K-30.00%119K-59.09%99K2,966.67%92K
Cash from discontinued investing activities
Operating cash flow -120.09%-3.09M-8.10%-7.37M-24.95%-1.83M-16.16%-2.5M-22.17%-1.63M24.60%-1.4M6.73%-6.82M43.94%-1.47M-41.25%-2.15M14.37%-1.34M
Investing cash flow
Cash flow from continuing investing activities 0-3,466.67%-107K-800.00%-27K-43K-29K-8K82.35%-3K40.00%-3K00
Net PPE purchase and sale --0-3,466.67%-107K-800.00%-27K---43K---29K---8K82.35%-3K40.00%-3K--0--0
Cash from discontinued investing activities
Investing cash flow --0-3,466.67%-107K-800.00%-27K---43K---29K---8K82.35%-3K40.00%-3K--0--0
Financing cash flow
Cash flow from continuing financing activities -99.03%130K206.30%13.71M-94.59%174K1,823.08%250K-104.19%-51K44,356.67%13.34M-25.84%4.48M-46.66%3.22M13K24,220.00%1.22M
Net common stock issuance --0239.49%13.44M--0--71K--0--13.37M-40.15%3.96M-49.48%3.34M--0--620K
Proceeds from stock option exercised by employees -13.33%130K-37.07%528K-3.87%174K1,284.62%180K-96.10%24K400.00%150K--839K--181K--13K--615K
Net other financing activities ----18.89%-262K--0---1K---75K---186K44.31%-323K---304K--0----
Cash from discontinued financing activities
Financing cash flow -99.03%130K206.30%13.71M-94.59%174K1,823.08%250K-104.19%-51K44,356.67%13.34M-25.84%4.48M-46.66%3.22M--13K24,220.00%1.22M
Net cash flow
Beginning cash position 71.32%14.97M-21.15%8.74M138.64%16.69M107.51%18.95M123.33%20.67M-21.15%8.74M-10.43%11.09M-8.90%6.99M-0.73%9.13M-13.97%9.25M
Current changes in cash -124.82%-2.96M367.33%6.27M-194.45%-1.65M-7.19%-2.3M-1,337.82%-1.71M750.93%11.93M-81.64%-2.35M-48.75%1.75M-40.39%-2.14M92.35%-119K
Effect of exchange rate changes --4K---36K---65K----------0--0--0--------
End cash Position -41.85%12.02M71.32%14.97M71.32%14.97M138.64%16.69M107.51%18.95M123.33%20.67M-21.15%8.74M-21.15%8.74M-8.90%6.99M-0.73%9.13M
Free cash flow -118.84%-3.09M-9.62%-7.48M-26.53%-1.86M-18.15%-2.55M-24.34%-1.66M24.17%-1.41M6.91%-6.82M43.94%-1.47M-41.25%-2.15M14.42%-1.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More